Prognostic impact of post-treatment FDG PET/CT in anal canal cancer: A prospective study-Reference-Cited by-同舟云学术

Prognostic impact of post-treatment FDG PET/CT in anal canal cancer: A prospective study

Published:2023-11 Issue: Volume:188 Page:109905
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Bailleux Caroline,Zwarthoed Colette,Evesque Ludovic,Baron David,Scouarnec Cyrielle,Benezery Karen,Chardin David,Jaraudias Claire,Chateau Yann,Gal Jocelyn,François Eric

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference26 articles.

1. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

2. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet. 1996, 348: 1049-1054.

3. Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I);Northover;Br J Cancer,2010

4. RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and Mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal;Kachnic;Int J Radiat Oncol,2013

5. Definitive intensity-modulated chemoradiation for ananlo squamous cell carcinoma: Outcome and toxicity of 428 patients treated at a single institution;Holliday;Oncologist,2022